Takeda Pharmaceutical TAK
NYSE TAK
$17.93 -0.26 (-1.40%)
As of: Oct 1, 2026 · 12:52 PM EDT

Takeda Pharmaceutical (TAK) Preferred Shares (2017)

Updated

Takeda Pharmaceutical (TAK) reported Preferred Shares of $82.2 million for the quarter ended Dec 31, 2017.

Analysis

Takeda Pharmaceutical (TAK) Preferred Shares (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Takeda Pharmaceutical 2.63 Bn -23.88 Bn 5.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 82.20 Mn
API Access

Takeda Pharmaceutical Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=TAK&period=max&api_key=YOUR_API_KEY